Zum Hauptinhalt springen

Naltrexon

09. November 2021 | Naltrexon

Low-Dose Naltrexone Co-Treatment in the Prevention of Opioid-Induced Hyperalgesia.

Low-Dose Naltrexone Co-Treatment in the Prevention of Opioid-Induced Hyperalgesia. Shaheed G, Manjooran AP, Reddy AJ, Nawathey N, Habib S, Brahmbhatt H. Cureus. 2021 Sep 2;13(9):e17667. doi: 10.7759/cureus.17667. PMID: 34646707; PMCID…

09. November 2021 | Naltrexon

The impact of age and genetics on naltrexone biotransformation.

The impact of age and genetics on naltrexone biotransformation. Stancil SL, Nolte W, Pearce RE, Staggs VS PhD, Leeder JS. Drug Metab Dispos. 2021 Nov 2:DMD-AR-2021-000646. doi: 10.1124/dmd.121.000646. Epub ahead of print. PMID: 3472851…

15. Juli 2021 | Naltrexon

Adverse drug reactions with naltrexone: Experience from an addiction treatment center.

Adverse drug reactions with naltrexone: Experience from an addiction treatment center. Sarkar S, Addagadda SS, Bhatia G, Chadda RK. Indian J Psychiatry. 2021 Mar-Apr;63(2):206-207. doi: 10.4103/psychiatry.IndianJPsychiatry_94_20. Epub…

08. Juni 2021 | Naltrexon

Cognitive performance of patients with opioid use disorder transitioned to extended-release injectable naltrexone from buprenorphine: Post hoc analysis of exploratory results of a phase 3 randomized controlled trial. (2)

Cognitive performance of patients with opioid use disorder transitioned to extended-release injectable naltrexone from buprenorphine: Post hoc analysis of exploratory results of a phase 3 randomized controlled trial. Kosten T, Aharonovich E…

08. Juni 2021 | Naltrexon

Monitoring and Improving Naltrexone Adherence in Patients with Substance Use Disorder.

Monitoring and Improving Naltrexone Adherence in Patients with Substance Use Disorder. Perez-Macia V, Martinez-Cortes M, Mesones J, Segura-Trepichio M, Garcia-Fernandez L. Patient Prefer Adherence. 2021 May 18;15:999-1015. doi: 10.2147…

18. Mai 2021 | Naltrexon

Life threatening opioid withdrawal syndrome due to inadvertent naltrexone administration and lifesaving result by clonidine.

Life threatening opioid withdrawal syndrome due to inadvertent naltrexone administration and lifesaving result by clonidine. Kurmi J, Choudhury HA. Indian J Psychiatry. 2020 Nov-Dec;62(6):742-743. doi: 10.4103/psychiatry.IndianJPsychia…

22. April 2021 | Naltrexon

Combining behavioral harm-reduction treatment and extended-release naltrexone for people experiencing homelessness and alcohol use disorder in the USA: a randomised clinical trial

Combining behavioral harm-reduction treatment and extended-release naltrexone for people experiencing homelessness and alcohol use disorder in the USA: a randomised clinical trial Collins, Susan E et al. The Lancet Psychiatry, Volume 8, Issue 4, 2…

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten